Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)

PHASE2TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

March 19, 2024

Study Completion Date

April 19, 2024

Conditions
COVID-19
Interventions
DRUG

Plitidepsin

IV infusion over 60-minutes

Trial Locations (44)

1121

Országos Korányi Pulmonológiai Intézet, Budapest

3000

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven

4600

Academician Vakhtang Bochorishvili Clinic, Tbilisi

10003

Hospital San Pedro de Alcantara, Cáceres

10676

General Hospital of Athens Evangelismos, Athens

11527

Laiko General Hospital of Athens, Athens

General Hospital for Thoracic Diseases Sotiria, Athens

11528

Alexandra General Hospital, Athens

16128

Ente Ospedaliero Ospedali Galliera, Genova

28006

Hospital Universitario de La Princesa, Madrid

28007

Hospital General Universitario Gregorio Marañón, Madrid

28033

MD Anderson Cancer Center Madrid, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

Hospital Universitario Fundación Jiménez Díaz, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28050

Hospital Universitario HM Sanchinarro, Madrid

28223

Hospital Universitario Quirónsalud Madrid, Pozuelo de Alarcón

29010

Hospital Regional Universitario de Málaga - Hospital General, Málaga

36213

Hospital Alvaro Cunqueiro - Clinico Universitario Vigo, Vigo

37007

Complejo Asistencial Universitario de Salamanca - Hospital Clínico, Salamanca

37044

Centre Hospitalier Régional Universitaire de Tours, Tours

45500

University Hospital of Ioannina, Ioannina

50009

Hospital Universitario Miguel Servet, Zaragoza

52621

Sheba Medical Center Hospital - Tel Hashomer, Ramat Gan

64109

Centre Hospitalier de la Côte Basque, Bayonne

67091

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

68024

Hôpitaux Civils de Colmar - Centre Hospitalier Louis Pasteur, Colmar

69373

Cancer Research Centre of Lyon, Lyon

0141

The First University Clinic of the Tbilisi State Medical University, Tbilisi

0144

Ltd Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi

124 62

University General Hospital Attikon, Athens

00149

IRCCS Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Roma

91-347

Wojewódzki Specjalistyczny Szpital im. Dr. Władysława Biegańskiego, Lodz

4835-044

Hospital da Senhora da Oliveira - Guimarães, Guimarães

1649-035

Centro Hospitalar Universitário Lisboa Norte, E.P.E - Hospital De Santa Maria, Lisbon

4464-513

Hospital Pedro Hispano, Senhora da Hora

4434-502

Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia

08916

Hospital Germans Trias i Pujol, Badalona

08003

Hospital del Mar - Parc de Salut Mar, Barcelona

08035

Vall d'Hebron Institut de Recerca, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

NE1 4LP

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

NW1 2BU

University College London Hospitals NHS Foundation Trust, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PharmaMar

INDUSTRY

NCT05705167 - Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA) | Biotech Hunter | Biotech Hunter